Barclays »

Turnstone Biologics Corp shares owned by Barclays

Quarter-by-quarter ownership of Turnstone Biologics Corp (TSBX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Turnstone Biologics Corp

Tip: Access up to 7 years of quarterly data

All positions including Turnstone Biologics Corp held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Turnstone Biologics Corp by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $318k 121k 2.62
2023-12-31 $295k 116k 2.54

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Turnstone Biologics Corp

OrbiMed Advisors
FMR
Point72 Asset Management
Bank of America Corporation
Citadel Advisors
BlackRock
Partner Fund Management
72 Investment Holdings
Eventide Asset Management
ExodusPoint Capital Management
Vanguard Group
Geode Capital Management
Fil
Zimmer Partners
Barclays

View all funds holding Turnstone Biologics Corp